Nevoid basal cell carcinoma syndrome: |
Multiple basal cell carcinomas; |
Cleft lip/palate |
Ocular anomalies |
Macrocephaly |
Calcification of the falx cerebri; |
Nevoid basal cell carcinoma syndrome 1 (PTCH1) |
Odontogenic keratocyst (OKC) of the jaw |
|
|
|
Palmar and plantar pits; Bifid or fused ribs; Medulloblastoma |
Nevoid basal cell carcinoma syndrome 2 (SUFU) |
|
|
|
|
Neurofibromatosis 1
(NF1)
|
Multiple café-au-lait macules; Cutaneous neurofibromas; Orbitofacial neurofibromatosis |
Optic pathway glioma |
Iris hamartomas (Lisch nodules) |
Orbital dysplasia |
Neurofibroma and MPNST; Skinfold freckling in the axillary, inguinal, and submammary regions; Duodenal neuroendocrine tumor |
|
|
|
|
|
Pheochromocytoma and paragangliomas |
|
|
|
|
|
Malignant peripheral nerve sheath tumour (MPNST); Rhabdomyosarcoma, Glomus tumours of the digits |
Familial adenomatous polyposis with Gardner syndrome variant
(APC)
|
Desmoid fibromatosis: maxillary sinus, nasopharynx, and oral cavity |
Bone osteomas |
Dental structures: supernumerary teeth |
Compound odontomas located in the anterior maxilla, or complex odontomas in the posterior mandible or anterior maxilla |
> 100 adenomatous colorectal polyps; Gastric and duodenal polyps; |
|
|
|
|
|
Cribriform morular thyroid carcinoma; Hepatobiliary tree and pancreas carcinoma; |
|
|
|
|
|
Childhood hepatoblastoma (1%); Adrenocortical adenomas /adenocarcinomas; medulloblastoma (< 1%); Adamantinomatous craniopharyngioma |
Brooke-Spiegler syndrome (CYLD)
|
Salivary gland basal cell adenoma, membranous-type, multicentric and bilateral |
Spiradenoma, cylindroma and spiradenocylindroma mainly involve the skin of the head and neck |
Trichoepitheliomas predominantly affect the nasolabial folds |
|
|
PTEN hamartoma tumor syndrome/Cowden syndrome: |
Papillomas on the lips, tongue, buccal mucosa; |
Mucocutaneous neuromas |
|
|
Adult Lhermitte-Duclos disease (cerebellar tumors); |
Cowden syndrome 1 (PTEN)
|
Facial trichilemmomas |
Breast cancer; |
Cowden syndrome 4 (KLLN)
|
|
Non-medullary thyroid cancer; |
Cowden syndrome 5 (PIK3CA)
|
|
Megalocephaly; Endometrial carcinoma; |
Cowden syndrome 6 (AKT1)
|
|
Cowden syndrome 7 (SEC23B)
|
|
Multiple GI hamartomas or ganglioneuromas |
Hereditary paraganglioma syndromes: |
|
|
|
|
|
SDH-deficient syndromes: |
|
|
|
|
|
PGL1 (SDHD)
|
H&N Paraganglioma (most common head and neck PGL: ~ 50%) |
|
|
|
Pheochromocytoma; Renal cell carcinoma; |
Gastrointestinal stromal tumor; |
Pituitary tumor |
PGL2 (SDHAF2)
|
H&N Paraganglioma |
|
|
|
|
PGL3 (SDHC)
|
H&N Paraganglioma |
|
|
|
Renal cell carcinoma; |
Gastrointestinal stromal tumor |
PGL4 (SDHB)
|
H&N Paraganglioma |
|
|
|
Renal cell carcinoma; |
Gastrointestinal stromal tumor; |
Pituitary tumor |
Abdomen and thorax paraganglioma |
PGL5 (SDHA)
|
H&N Paraganglioma |
|
|
|
Pheochromocytoma; Renal cell carcinoma; |
Gastrointestinal stromal tumor; |
Pituitary tumor |
Multiple endocrine neoplasia type 2/MEN2 (RET)
|
H&N Paraganglioma rare |
|
|
|
Medullary thyroid carcinoma; |
Parathyroid proliferations; |
Oral ganglioneuromas; Mucosal neuromas oropharynx, lips, and eyelids |
Pheochromocytoma |
VonHippel-Lindau (VHL)
|
H&N Paraganglioma rare |
Central nervous system and retinal hemangioblastoma |
|
|
Clear cell renal cell carcinoma; |
Neuroendocrine tumors; |
Endolymphatic sac tumor of middle ear |
Pancreatic serous cystadenomas |
Neurofibromatosis type 1 (NF1)
|
H&N Paraganglioma rare |
|
|
|
Neurofibroma and MPNST; Ocular manifestations; Duodenal neuroendocrine tumor |
Others syndromes/genes: MAX; TMEM127; FH; KIF1B; EGLN1,2,3; EPAS1; MEN1
|
H&N Paraganglioma rare |
|
|
|
|
Multiple endocrine neoplasia type 2B/MEN2B
(RET)
|
Oral ganglioneuromas; Mucosal neuromas in MEN 2B can involve the oropharynx, lips, and eyelids |
Thickened corneal nerves |
|
|
Medullary thyroid carcinoma; Pheochromocytoma; Parathyroid proliferations; |
Oral and intestinal ganglioneuromas; Marfanoid body habitus |
Hyperparathyroidism-Jaw tumour syndrome
(CDC73)
|
Cemento-ossifying fibroma |
Parathyroid adenoma and carcinoma |
Fibro-osseous jaw lesions |
|
Renal and uterine tumours |
Li-Fraumeni syndrome: |
H&N and laryngeal carcinomas |
Squamous cell carcinomas larynx, pharynx and oral cavity |
|
|
Breast, soft tissue, bone, brain, adrenal glands, and female genital tract carcinomas |
Li–Fraumeni syndrome (TP53-associated) |
Li–Fraumeni syndrome (CHEK2-associated) |
Fanconi anemia
(FANCA)
|
Head and neck squamous cell carcinoma (FA-HNSCC) frequently present as poorly differentiated |
Oral potentially malignant disorders (OPMD) |
|
|
Increased risk for hematologic and solid malignancies |
Dyskeratosis congenita
(DKCA)
|
Oral leukoplakia |
Oral leukoplakia seen on the tongue |
|
|
Triad of oral leukoplakia, nail dystrophy, and reticulate hyperpigmentation; |
Bone marrow failure; Increased malignancy; Lung and liver diseases |
Ataxia telangiectasia syndrome
(ATM)
|
Head and neck squamous cell carcinoma (HNSCC) |
Lymphoid neoplasms of the B and T-cell lineage in the head and neck, including involvement of the Waldeyer ring |
Telangiectases in sun exposed areas as bulbar conjunctiva and bridge of nose |
|
Neurologic manifestations and conjunctival telangiectasias |
Bloom syndrome
(BLM)
|
Head and neck squamous cell carcinoma (HNSCC) |
Rash on cheeks and nose |
|
|
Small size and lack of subcutaneous tissue |
Men and infertile and women have early menopause |
Colorectal and breast cancer |
Von-Hippel Lindau syndrome
(VHL)
|
Endolymphatic sac tumor, bilateral |
Hemangioblastomas cerebellum, spinal cord, brain, and retina |
|
|
Kidney cysts |
and renal cell carcinomas; |
Adrenal pheochromocytomas and extraadrenal paragangliomas; |
Pancreatic neuroendocrine tumors; Cysts and serous cystadenomas |
Tuberous sclerosis syndrome: |
Predominantly cutaneous and oral manifestations; |
Fibrous cephalic plaques in forehead and scalp |
Dental enamel loss on the incisal border and tooth |
|
Cutaneous angiofibromas; Shagreen patches; Subungual fibromas; Cardiac rhabdomyomas; Pulmonary lymphangioleiomyomatosis; |
Tuberous sclerosis type 1 (TSC1)
|
Facial angiofibromas; |
Tuberous sclerosis type 2 (TSC2)
|
Shagreen patches and poliosis in scalp |
Renal angiomyolipomas |